Prescott Group Capital Management L.L.C. Buys New Stake in 908 Devices Inc. (NASDAQ:MASS)

Prescott Group Capital Management L.L.C. purchased a new position in shares of 908 Devices Inc. (NASDAQ:MASSFree Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 150,000 shares of the company’s stock, valued at approximately $330,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of MASS. Charles Schwab Investment Management Inc. grew its holdings in 908 Devices by 14.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 220,477 shares of the company’s stock valued at $765,000 after purchasing an additional 28,015 shares during the period. Geode Capital Management LLC grew its position in 908 Devices by 1.2% in the third quarter. Geode Capital Management LLC now owns 567,788 shares of the company’s stock valued at $1,970,000 after acquiring an additional 6,634 shares in the last quarter. State Street Corp increased its stake in 908 Devices by 1.2% during the 3rd quarter. State Street Corp now owns 479,044 shares of the company’s stock worth $1,662,000 after buying an additional 5,704 shares during the period. Barclays PLC increased its position in shares of 908 Devices by 452.7% during the third quarter. Barclays PLC now owns 46,214 shares of the company’s stock worth $160,000 after acquiring an additional 37,853 shares during the last quarter. Finally, Concurrent Investment Advisors LLC purchased a new stake in 908 Devices during the 4th quarter worth approximately $52,000. 88.06% of the stock is owned by hedge funds and other institutional investors.

908 Devices Stock Performance

Shares of NASDAQ:MASS opened at $3.01 on Friday. 908 Devices Inc. has a one year low of $1.81 and a one year high of $7.56. The company has a market capitalization of $104.82 million, a PE ratio of -1.70 and a beta of 0.99. The stock has a fifty day moving average of $2.51 and a 200-day moving average of $2.94.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of 908 Devices in a research report on Wednesday, February 19th. Stephens reaffirmed an “overweight” rating and issued a $6.00 target price on shares of 908 Devices in a research report on Wednesday, January 15th. Stifel Nicolaus dropped their price target on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Leerink Partners restated a “market perform” rating and set a $4.00 price objective (down from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Finally, Leerink Partnrs cut 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, 908 Devices currently has an average rating of “Moderate Buy” and an average price target of $5.33.

View Our Latest Report on MASS

908 Devices Company Profile

(Free Report)

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.

Read More

Want to see what other hedge funds are holding MASS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 908 Devices Inc. (NASDAQ:MASSFree Report).

Institutional Ownership by Quarter for 908 Devices (NASDAQ:MASS)

Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.